Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AGEN-2373 by Agenus for Castration-Resistant Prostate Cancer (CRPC): Likelihood of Approval
AGEN-2373 is under clinical development by Agenus and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC). According to GlobalData,...
AGEN-2373 by Agenus for Adrenal Gland Cancer: Likelihood of Approval
AGEN-2373 is under clinical development by Agenus and currently in Phase I for Adrenal Gland Cancer. According to GlobalData, Phase...
AGEN-2373 by Agenus for Castration-Resistant Prostate Cancer (CRPC): Likelihood of Approval
AGEN-2373 is under clinical development by Agenus and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC). According to GlobalData,...